- InMode Ltd (NASDAQ:INMD) expects Q2 sales of $113.0 million - $113.3 million, beating the consensus of $103.13 million.
- The company sees the adjusted EPS of $0.57 to $0.58, surpassing the consensus of $0.51, with a gross margin of 83% - 85%.
- For FY22, InMode forecasts sales of $425 million - $435 million, up from prior guidance of $415-$425 million.
- "Our record results in the second quarter of 2022 are an indication of the strong demand for our proprietary technologies in the aesthetic surgical field. This positive momentum reinforces our confidence going into the second half of the year, and we are happy to increase our full-year guidance range from $415-$425 million to $425-$435 million," commented Moshe Mizrahy, InMode's CEO.
- InMode will release its second quarter of 2022 financial results on July 28.
- Price Action: INMD shares are up 11.70% at $25.80 during the premarket session on the last check Tuesday.
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。
精彩评论